Home Blog Page 48

The Monthly Fees in 55+ Communities Are Rising Faster Than Social Security

0
The Monthly Fees in 55+ Communities Are Rising Faster Than Social Security


Quick Read

  • Community fees rising between 3 and 5 percent annually against Social Security’s 2.5 percent COLA roughly triple a $325 monthly fee over 25 years.

  • Affording a 55+ community requires somewhere between $900,000 and $1.1 million in invested assets and a 3.5% withdrawal rate to buffer rising fees.

  • Communities with reserve ratios below 50% risk sudden 20% fee spikes, making a low-fee underfunded community costlier long-term than a pricier well-funded one.

  • Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; learn more here.

This is one of those retirement questions that sounds like a lifestyle choice and turns out to be a math problem. Someone in their early sixties tours a 55+ community, likes the pickleball courts, the maintenance-free landscaping, and the promise that the monthly fee handles everything. They pencil it into the budget alongside Social Security and call it settled. Then five years pass, the fee climbs faster than the check does, and the arithmetic that looked sturdy at closing starts to tilt. The scenario is worth working out carefully because the gap between a 55+ community fee schedule and the Social Security cost-of-living adjustment compounds in a way most planning conversations skip.

Frame Craft 8 / Shutterstock.com

What a 55+ Community Actually Costs to Run

What you pay each month really depends on where you land and what the community offers. A basic active-adult neighborhood typically runs $150 to $350 per month, while resort-style communities with golf, multiple pools, and dining can easily hit $350 to $700 or more. The Villages in Florida charges a $204 monthly amenity fee for new 2026 buyers, on top of bond payments and separate maintenance charges. Insurance drives costs in coastal Florida and the Carolinas, labor pushes fees higher in California and the Northeast, and reserve funding is the hidden layer beneath it all.

_________________________________

What’s Your Number…?

Here’s a question most people 5y from retirement can’t answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset’s free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)

__________________________________________

Assume a couple, age 66, buying into a mid-tier community at $325 a month, or $3,900 a year. On top of the fee, the household still owes property taxes, homeowners insurance on the individual unit, utilities, and everything the master policy does not cover. Healthcare adds a fixed floor. Medicare Part B alone is $202.90 per month in 2026 per beneficiary. The Part B annual deductible is $283, and the Part A inpatient deductible is $1,736 if anyone lands in the hospital. A realistic all-in budget for a paid-off home in this kind of community lands somewhere between $70,000 and $90,000 a year, in line with the BLS figure of $78,535 in average annual household expenditures.



Source link

3-year bachelor’s degrees are growing across the U.S. as college costs soar

0
3-year bachelor’s degrees are growing across the U.S. as college costs soar

Giles Sims, 34, was sick of getting passed over for jobs because he didn’t have a college degree.

But with a wife and a widowed mother to help support, he needed a quick solution. So the laid-off web developer turned to one of a growing number of three-year degree programs.

“I can’t afford to be out of the workforce for four years. That just seems like forever, and the three-year made it seem less daunting,” said Sims, a student at Ensign College, a private Salt Lake City school that recently changed all its bachelor’s degrees to require fewer classes than a traditional four-year degree.

The condensed programs have exploded in popularity. As of this spring, 26 U.S. states have a college that offers at least one reduced-credit, three-year bachelor’s, according to the nonprofit research group RAND.

Advocates say these programs are a solution to the college affordability crisis and a godsend for non-traditional students like Sims.

Critics, however, worry that they’ll narrow too much what students learn, confuse employers, limit graduate school options and create headaches in fields that require state licenses.

The American Association of University Professors, for one, says the programs devalue the meaning of a college credential.

“This is not innovation. This is just cutting corners,” said Todd Wolfson, AAUP’s president.

A new option to graduate more quickly, but with reduced credit

For decades, colleges have offered accelerated programs that let students finish faster, often by forgoing long summer breaks, maximizing transfer credits and condensing semester-long courses into shorter, five- to 10-week terms.

But those programs maintained the same course load, measured as credits. The new programs let students finish faster by completing as few as 90 credit hours. That shaves a year off the typical 120-hour bachelor’s degree.

Three-year bachelor’s degrees are common in other countries including the United Kingdom, India, France and Italy. But they can create complications for graduates seeking admission to U.S. graduate schools, which sometimes require extra coursework.

Some of the earliest colleges in colonial America, modeled after English institutions like Oxford and Cambridge, initially had three-year degrees, said John Thelin, the author of “A History of American Higher Education.” By the 19th century, the four-year format had taken hold, partly because there wasn’t an established system of public high schools to prepare students, Thelin said.

“The colleges would have to kind of start from scratch,” he said.

A change in accreditation opened the door to shorter degrees

The idea of bringing three-year degrees to the U.S. got attention in 2009 when Robert Zemsky, the founding director of the Institute for Research on Higher Education at the University of Pennsylvania Graduate School of Education, argued in a Newsweek cover story that three-year degrees could shake up a broken system.

But there was a roadblock, he recalled recently. “Accreditors said, ‘College is 120 credits, not 90 credits,’” he said.

Years passed. And in 2022, amid mounting concerns about college affordability, Zemsky helped revive the idea. The College-in-3 Exchange was born, and dozens of higher education institutions joined the network to look for ways to help students get degrees faster.

The Northwest Commission on Colleges and Universities was the first accreditor to say yes in 2023, when it approved reduced-credit programs at Ensign and Brigham Young University-Idaho. Other accreditors quickly followed.

As of May, 119 reduced-credit programs had been publicly announced, according to the RAND analysis, which was conducted to help education officials in Ohio as they weigh the feasibility of reduced-credit degrees.

It comes at a time when tuition and fees averaged $11,950 for in-state students at public schools and $45,000 at private nonprofits last school year, although many students get discounts that reduce the price, according to a report from the College Board, the nonprofit that oversees the SAT.

Some degrees are easier to compress

Private nonprofit schools offer three-quarters of the reduced-credit programs, frequently online. Typically, they compress the majors by reducing electives. Business degrees in fields such as marketing and management are the most common, followed by computer and information sciences.

Other majors, such as engineering, with its extensive math requirements, have been harder to shrink. And RAND found just six reduced-credit degrees in teacher education, which involves real-world experience requirements and state licensure.

Jill Cohen, 42, lives on a ranch in rural Yoder, Colorado, and is completing her teaching degree through one such program at Indiana Wesleyan.

She quit her old job selling life insurance and turned to teaching after a farming accident nearly claimed her life. Already, she is in the classroom, teaching middle school English, as she works on the degree through a special “Grow Your Own” program designed to address staff shortages.

Because her home is busy — she has twin 12-year-olds, along with a menagerie that includes horses, goats and chickens — she appreciates the streamlined degree.

“Why do I need to take, you know, underwater basket weaving when I could just take the evolutionary structure of the English language — what I’m going to be teaching,” she said.

However, programs with state licensing requirements are one of the biggest worries for Jenna Kramer, a policy researcher at RAND.

Indiana Wesleyan, which has a growing slate of reduced-credit offerings, said its education programs are specifically designed to meet Indiana licensing requirements. Students from elsewhere will need to check if the programs meet their state requirements, said Pam Downing, the school’s director of communications, in an email.

The RAND report also found the programs are so new that there are no standard practices for admitting three-year degree recipients into graduate school.

Students acknowledge it’s a gamble

Gabriella Staten, a 20-year-old student in the reduced-credit digital marketing program at Mount Mary University, a Catholic women’s institution in Milwaukee, estimates it will save her at least $20,000. While she sometimes wonders whether employers will take her degree as seriously as a four-year degree, she decided she could prove herself.

“Even if they were to look a little bit down on the three-year pathway, I can show them otherwise with the work,” she said.

Wesley Hardy, who is three semesters into a bachelor of applied science in accounting at Ensign, also sees the pros and cons. He likes that the three-year format will get him into the workforce faster.

But he noted that the requirements to become a certified public accountant — something he has considered — vary by state. Many require 120 semester hours to sit for the exam and 150 to become licensed. Graduate school often is needed.

Bruce Kusch, president of Ensign, said he has talked to multiple college presidents and doesn’t anticipate that graduate school will be a problem. But Hardy, 22, has questions about how it would work.

“Would I have to take extra classes?” he asked. “It’s definitely something I’ve thought of.”

___

The Associated Press’ education coverage receives financial support from multiple private foundations. AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.



Source link

Semiconductor Stocks Slide Ahead of NVIDIA Earnings: Intel Falls 5%, AMD Slides 4%, Taiwan Semiconductor Slips 3%

0
Semiconductor Stocks Slide Ahead of NVIDIA Earnings: Intel Falls 5%, AMD Slides 4%, Taiwan Semiconductor Slips 3%


Quick Read

  • Intel leads chip stocks lower, tumbling 5% while AMD drops 4% as traders trim exposure two sessions before Nvidia reports earnings Wednesday.

  • Nvidia has beaten EPS estimates four straight quarters yet averages a negative 2% day-of move, leaving SOXX vulnerable regardless of Wednesday’s headline result.

  • Druckenmiller’s Duquesne exited Intel, Micron, and Broadcom by June 30 while opening a new AMD position representing 0.8% of reported assets.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Taiwan Semiconductor Manufacturing didn’t make the cut. Grab the names FREE today.

Chip stocks are leading a narrow de-risking Monday morning, with the iShares Semiconductor ETF (NASDAQ:SOXX) down 4% to $501.17 while the iShares U.S. Technology ETF (NYSEARCA:IYW) is down 2% to $243.24. Semis are selling roughly twice as hard as broad technology, and that gap marks the session as sector-specific rather than a general tech pullback.

Thinkstock

Intel (NASDAQ:INTC) stock is down 5% to $85.98 and leads the group lower. Meanwhile, AMD (NASDAQ:AMD) stock is down 4% to $454.36, while Taiwan Semiconductor (NYSE:TSM) stock is down 3% to $406.40. No company-specific headline is driving Intel today, and positioning is being trimmed across the group two sessions before NVIDIA (NASDAQ:NVDA) reports its most consequential quarter of the year.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Taiwan Semiconductor Manufacturing didn’t make the cut. Grab the names FREE today.

De-Risking Into a Sector Catalyst

NVDA price target
NVDA Price Target — 24/7 Wall St.

NVIDIA reports its second-quarter fiscal 2027 results on August 26 after the close, a company-confirmed date. Given NVIDIA’s dominant weight in semiconductor benchmarks, the company’s guidance sets the tone for the entire complex, and traders are trimming exposure ahead of the release. Options flow points the same way: NVIDIA’s full-chain put-call ratio sits at 0.61, with the earnings-week expiration running a heavier 0.82. Intel stock is the most extended large-cap name in the group after an enormous year, and traders holding large gains often trim aggressively into high-variance catalysts. Intel stock was up 144% year to date through Friday’s close, which makes it the natural source of funds when investors reduce chip exposure.

NVIDIA’s own pattern reinforces the caution: the company has beaten Wall Street EPS estimates in four consecutive quarters, yet the average day-of price change across the last five reports was down 2%. The most recent quarter closed down 2% on release despite a 5.4% EPS surprise, and guidance nuance around China Data Center compute and Blackwell cadence has driven the reaction function more than headline numbers (the power, cooling, and networking suppliers behind that Blackwell buildout are the focus of a free report you can grab here). That history suggests a beat alone is unlikely to lift the entire complex.



Source link

BUILDon down 14%, but Spot buyers scoop $71.5K in one day – Is $18.9 in sight?

0
BUILDon down 14%, but Spot buyers scoop $71.5K in one day - Is $18.9 in sight?


BUILDon [B] has seen one of the major declines in the past day, with the asset plummeting 14% in the early hours of the day and bringing its cumulative 90-day performance to around 50%.

The asset is now trading at a key support level within a descending channel, which could be instrumental in determining whether it sees a rebound or, in fact, rallies even higher.

The price could rebound because the current support level sits within a demand zone that recently pushed B higher. If this demand holds, the market could continue trading upward, with its closest ceiling being the descending resistance line.

B price chart.
Source: B/USDT on TradingView

The rebound, however, may not happen immediately, especially when accounting for the fact that the demand zone extends even lower. There is a possibility that the price could drop further into this demand zone and consolidate before seeing a rebound.

In a very bullish scenario, the asset could breach the upper resistance level and trade even higher, with the next target being $18.9.

What should traders expect?

The indicator chart analysis shows that there has been significant distribution of the asset over the past few days, as recorded by the Accumulation/Distribution indicator.

The A/D is a volume-weighted indicator that shows high selling volume for B in the market, as demand remains very weak and supply continues to grow. At the time of writing, 972 million B has been distributed, with the indicator still pointing downward.

B accumulation distribution indicator.B accumulation distribution indicator.
Source: B/USDT on TradingView

This means that the price is still likely to extend lower, as the Bull Bear Power, an indicator that tracks whether bulls or bears are in control, shows that the latter remains in control.

With the bears in control, there is still a high chance that more selling could occur.

The dominance of the bears and the ongoing distribution mean that the price is likely to swing lower, potentially falling below the present support level and deep into the demand zone on the chart.

Structural buys remain

There has been an observable pattern in the market, with buying pressure growing over the past 10 days.

B remains bearish, but strong spot market buying could support a rally, with roughly $138,000 worth of B accumulated over the past three days. To put this into context, the majority of these purchases came within the past day, with $71,500 recorded.

B spot flowB spot flow
Source: CoinGlass

Buying at this scale while the price is declining implies that investors in the market remain convinced about the asset’s performance. They anticipate a possible rebound and view the decline as an opportunity to buy at a discount.

This trend has continued to support buying over the past 10 days. Continued buying in this case would support the bullish case, aid the market’s recovery, and potentially prevent the decline from extending much further below its present level.


Final Summary

  • BUILDON is holding a key demand zone that could support a rebound toward the descending resistance.
  • Bearish indicators remain dominant, but sustained spot accumulation could help B defend its current support and recover.



Source link

Anthropic Is Chasing a $2 Trillion IPO. Its Most Powerful AI Model Is Raising a Big Red Flag

0
Anthropic Is Chasing a $2 Trillion IPO. Its Most Powerful AI Model Is Raising a Big Red Flag


Quick Read

  • Anthropic’s revenue surged sevenfold to $65B annualized, supporting a planned $2 trillion IPO with $200B in revenue targeted by 2028.

  • Anthropic’s most powerful Fable 5 model stalled at just 11% of corporate AI spending, while the cheaper Opus 5 surpassed it within weeks.

  • If customers keep choosing cheaper ‘good enough’ models over frontier AI, Anthropic’s $200B revenue target by 2028 becomes significantly harder to reach.

  • Don’t wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

The AI market has entered a new phase. Early buyers were willing to pay almost any price for the most capable models, but businesses are now asking a more ordinary question: How much intelligence do we actually need for the job? 

24/7 Wall St.

That shift is important because frontier AI companies have built their valuations around enormous spending on chips, data centers, and model training. Anthropic sits at the center of that bet. The private AI company is reportedly preparing for an October IPO at a valuation of $2 trillion or more — potentially surpassing the record set by SpaceX (NASDAQ:SPCX), which went public in June at $1.77 trillion.

The $200 Billion Revenue Bet

Anthropic’s growth numbers explain why investors are willing to entertain a $2 trillion valuation. Its annualized revenue run rate jumped from roughly $9 billion at the end of 2025 to $47 billion in May and more than $65 billion by the end of July. Reuters reported that Anthropic is projecting roughly $190 billion to $200 billion of revenue in 2028.

A $2 trillion valuation against $200 billion of 2028 revenue would represent roughly 10 times sales. That’s hardly a bargain, but it looks less extreme if Anthropic can actually compound revenue at anything approaching its current pace.

There is evidence supporting the bull case. Anthropic told investors it had 6,000 customers spending at least $100,000 annually, while it recorded its first adjusted operating profit in the second quarter and expects to remain profitable in the third.

Don’t wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

But a new Financial Times report introduces a problem that investors cannot simply wave away.

24/7 Wall St.

A $2 trillion valuation meets a cutthroat market. As Anthropic aims to surpass SpaceX, customers are already choosing ‘good enough’ over the most expensive AI. © 24/7 Wall St.

The Most Expensive Model Isn’t Winning

According to the site, spending on Anthropic’s most powerful and expensive model, Fable 5, has plateaued at only about 11% of spending on Anthropic’s tools more than two months after launch. The data comes from Ramp’s analysis of corporate spending. More importantly, Anthropic’s cheaper Opus 5 had already surpassed Fable 5 in business spending shortly after its late-July release.



Source link

Women’s Health Diagnostics Gap Isn’t About Missing Tests

0
Women's Health Diagnostics Gap Isn't About Missing Tests


Kim Trowbridge spent years hearing that her broken sleep, shifting weight, and climbing cholesterol were just menopause. A Function member and retired environmental consultant from Cleveland kept getting standard panels. Nobody went deeper. When she finally pushed and joined Function, 10 of her 13 cardiovascular markers came back out of range, including elevated Lp(a) and hs-CRP, with no family history of heart disease.

“People are going around the traditional medical system because it’s not serving them,” she explains.

The women’s health diagnostics gap is almost always described the same way: Women don’t get tested. That framing is incomplete, and the company sitting on 100 million lab results has the receipts. More than half of Function’s members are women, and its co-founder’s history points to something less convenient than missed tests. The blood got drawn. The numbers came back. Nobody translated them.

The Tests Were Ordered, The Symptoms Were Not Believed

Pranitha Patil, Function’s co-founder and chief business officer, was a teenager with three things happening at once: symptoms of what was then called PCOS and now called PMOS, prediabetes, and total cholesterol north of 250. I asked what the system failed to give her. A test never ordered? A result never explained?

Neither, she corrected me. “It wasn’t actually that the tests weren’t given to me,” Patil said. “It was that the symptoms, like showing up in me as a young female, were not necessarily taken seriously.”

She was too young for statins. Her prediabetes didn’t show up in her body weight, so it didn’t look like prediabetes. The answer to the rest was birth control, which she describes as the catch-all of the era. At 20, she recalls a physician telling her she would be on medication for the rest of her life and should get prepared for it. She started running experiments on herself instead.

A Name That Hid The Whole Condition

Medicine has since conceded her point in the most literal way available. On May 12, 2026, a coalition of 56 patient and professional organizations renamed polycystic ovary syndrome polyendocrine metabolic ovarian syndrome, or PMOS.

The old name implied ovarian cysts that aren’t pathological cysts at all, obscured the condition’s endocrine and metabolic reality, and contributed to diagnostic delays affecting up to 70% of patients. Patil’s cholesterol and prediabetes weren’t unrelated complications. They were the condition, filed under a name that pointed everyone to her ovaries.

Fifteen years later, Holly Strickland’s version is nearly identical. A Function member and 34-year-old emergency room nurse and mother of two in Houston, she spent more than a decade exhausted, blaming school, then pregnancy, then hormones, caffeinating through shifts, and napping to survive. Function’s diagnostic panel flagged thyroid antibodies that the company reports were roughly 75 times the normal range. The diagnosis was Hashimoto’s thyroiditis.

“I spent over a decade being told I was fine when I wasn’t,” she said. She works inside the system that couldn’t answer her.

Knowing What To Ask For Is The Real Barrier

The obvious objection: If these tests exist and insurance covers them when a doctor orders them, why are women paying $365 a year out of pocket?

Patil rejects the premise. Many of these panels aren’t actually covered, she argues, because they require diagnostic codes patients don’t have, and the bill still lands on the patient. Her sharper point sits upstream of billing. “You, as a patient, may not know what to ask for,” she observed. “How are we to expect the average American on the street to know what to ask for or to know how to communicate” inside a system she calls hierarchical and intimidating to push back against.

What Function exposes, in her telling, isn’t a missing test. It’s “the how in which the system was built.”

When Patients Dismiss Themselves

The translation gap starts before the appointment. Jennifer, another Function member and nurse who asked that her last name not be used, spent about a year having her hair loss and fatigue dismissed at 37. Her ferritin came back at 5 ng/mL, low enough that her doctor sent her for a colonoscopy well ahead of the standard screening age. “Without those labs, I would have dismissed my symptoms, and I would have never gotten this colonoscopy,” she said.

What Function’s Own Data Shows About Women

Function’s base membership has included AMH, estradiol, FSH, LH, prolactin, SHBG and testosterone since launch, markers routine physicals have historically skipped. At scale, three patterns stand out.

About 15% of women tested showed elevated thyroid antibodies despite normal TSH, meaning a standard thyroid screen would clear them.

FSH levels doubled between members’ 20s and 30s, suggesting perimenopause may begin earlier than clinical convention assumes.

Seven percent of members showed elevated hs-CRP, Lp(a), and LDL cholesterol together, a combination that compounds cardiovascular risk, particularly in women.

Patil sees one story running through it all. “Folks are coming in with abnormal or sub-optimal biomarkers while they’re being told that everything is normal when they’re feeling unwell,” she noted. Women are known to present differently during heart attacks. Apply that to everything medicine hasn’t studied, she added, and “imagine the things we don’t know.”

None Of It Is Published Yet

Asked whether Function is producing peer-reviewed research or white papers on these findings, Patil was straight: it’s an ambition, not a practice. The company needs more years of longitudinal data before it can claim one thing causes another. That ambition has since acquired an address. In August, Function announced a research partnership with NYU Grossman School of Medicine to build early-detection models from its longitudinal data, with peer-reviewed publication promised. The stated agenda names cancer, brain health and cardiometabolic risk.

Building AI On Research That Left Women Out

Function launched its Medical Intelligence Lab alongside a $298 million Series B and has since raised another $450 million from General Catalyst’s Customer Value Fund, a non-dilutive, growth-financing vehicle designed to finance sales and marketing. Here’s the trap. Medical AI learns from a literature base that excluded women for decades, so building on it automates the dismissal.

Patil knows. “The AI is only as good as the data it’s trained on,” she acknowledged, and “we know that women were not included in research for so many years.”

Her workaround is genuinely interesting. Rather than chase a better population average, Function bets on your own history as the reference point. “This is the best comparison set, not on average a female,” she explained.

The company’s connectors let members push their results into ChatGPT, Claude, Copilot, and Perplexity so answers reflect their biology instead of generic data. More than 200 million people ask AI a health question weekly, and most answers come from population-level generalizations.

The limit is real, and she doesn’t hide it. A personal baseline tells you what changed. It can’t tell you what’s abnormal without reference ranges drawn from the same thin research. “We’re running experiments on ourselves until this is like formally complete,” Patil conceded, putting the horizon at five to 10 years.

Why She Won’t Call It A Women’s Health Company

Function is functionally one of the country’s largest women’s diagnostics platforms and refuses the label.

That wasn’t strategy, Patil insists. “We genuinely believe that Function is meant for all, and we happen to attract women.” Naming it a women’s health company would cut out half of what health actually is. Fertility isn’t one person’s project, she points out, and neither is anything else that happens inside a family.

Her argument runs deeper than positioning, “Women’s health is a core part of understanding human health. It’s not a separate category, it never has been.”

Which leaves the uncomfortable math. If a platform built for everyone tips majority female, the market is telling on itself. “We’re so dismissed, there’s not enough research, we’re like the center of so many households,” Patil said.

Strickland put the same thing in fewer words, “So many women think they’re dealing with depression or anxiety when it could be their thyroid.”



Source link

Lighter crypto rallies 20% as Upbit and CFTC catalysts lift price – Can LIT reach $4?

0
Lighter crypto rallies 20% as Upbit and CFTC catalysts lift price - Can LIT reach $4?


Lighter [LIT] spent most of August compressing between $2.00 and $2.45, quietly absorbing supply before the breakout.

That compression continued to absorb excess supply beneath the supply ceiling until it ended when the price cleared $2.80, peaked at $2.99, and briefly fell back to $2.60.

Bulls regained control and pushed the price higher, breaking through $3.00 and entering a new steep expansion upward to $3.7760.

At press time, the altcoin was up 20% in the last 24 hours, extending its weekly gain to 52%. Momentum confirmed the acceleration, as the MACD remained positive and its histogram recorded the widest spread in the period.

Source: TradingView

Meanwhile, RSI reached 77.81, placing the price firmly within overbought conditions. Volume also rose during both breakout legs, although the latest candles attracted less participation than the initial push.

After clearing its former range, LIT now faces supply at $3.77, where the latest impulse stalled. Absorbing that pressure would extend price discovery toward $4.00, while $3.20–$3.30 continues anchoring the breakout.

Together, this simply defines a strong but extended structure for the altcoin, with momentum expanding faster than fresh volume.

CFTC role and Upbit listing fuel LIT’s rally

As LIT extended its breakout with another 20% session, two announcements provided fresh catalysts for market attention. On one hand, Lighter’s founder, Vladimir Novakovski, was appointed to the CFTC Innovation Advisory Committee during its inaugural meeting.

The appointment linked Lighter more directly with U.S. discussions on decentralized derivatives and compliance frameworks. On the other hand, South Korea’s dominant exchange, Upbit, scheduled the LIT/KRW listing with trading scheduled to begin at 13:00 local time on the 24th of August.

Source: UpBit

Together, the developments created two distinct market catalysts around the rally.

The regulatory visibility strengthened Lighter’s institutional relevance as the Upbit listing widened retail access and potential liquidity. Therefore, LIT’s acceleration aligned with both policy and exchange catalysts.

LIT derivatives activity intensifies

The latest advance reshaped LIT’s derivatives market, as leverage expanded alongside price. Open Interest surged by 25.37% to $332.4 million. This shows that traders added exposure during the rally.

Source: Coinalyze

Meanwhile, according to CoinGlass data, the 24-hour liquidations reached $2.42 million, with shorts accounting for $1.96 million of that total, while longs accounted for only $458,440. In addition, most liquidations were completed within 12 hours, and liquidations topped at $2.18 million.

Source: CoinGlass

This concentration confirms rising prices cleared bearish positions rapidly, strengthening the upward impulse. However, the liquidation map shows fresh leverage gathering around nearby levels.

Source: CoinGlass

Liquidity bands remain visible near $3.60 and above $3.80, while heavier downside clusters extend toward $3.40. Therefore, derivatives activity supported momentum but also tightened price exposure around increasingly crowded leverage zones.

Still, with Open Interest up 25.37%, forced closures around either zone can amplify LIT’s next move.


Final Summary

  • Lighter jumped 70%, while $3.20–$3.30 support keeps $4 within reach.
  • Upbit and CFTC developments increased interest, while rising leverage raised volatility.



Source link